# Novartis AG: Form 6-K, filed Jul 18, 2023

- Company: [Novartis AG](/companies/nvs.md) (CIK 1114448)
- Form: 6-K
- Filed: 2023-07-18
- Accepted by EDGAR: Jul 18, 2023, 07:30 ET
- Period: 2023-06-30
- Accession: 0001370368-23-000059
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1114448/000137036823000059/nvs-20230630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1114448/000137036823000059/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1114448/000137036823000059/nvs-20230630.htm

Filed Jul 18, 2023.
Source: SEC EDGAR, the filing index for accession 0001370368-23-000059. Last ingested by Listed: Nov 13, 2026, 16:23 ET. No prices; not investment advice.
